AQR Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-37,264
| Closed | -$1.08M | – | 3800 |
|
|
2025
Q4 | $1.08M | Sell |
37,264
-9,456
| -20% | -$180K | ﹤0.01% | 2502 |
|
|
2025
Q3 | $363K | Sell |
46,720
-158,467
| -77% | -$1.19M | ﹤0.01% | 2981 |
|
|
2025
Q2 | $1.52M | Sell |
205,187
-563
| -0.3% | -$4.95K | ﹤0.01% | 1946 |
|
|
2025
Q1 | $1.77M | Buy |
+205,750
| New | +$3.17M | ﹤0.01% | 1676 |
|
|
2024
Q1 | – | Sell |
-1,262
| Closed | -$73.2K | – | 2468 |
|
|
2023
Q4 | $73.2K | Sell |
1,262
-4,465
| -78% | -$180K | ﹤0.01% | 2291 |
|
|
2023
Q3 | $182K | Buy |
5,727
+2,845
| +99% | +$135K | ﹤0.01% | 2154 |
|
|
2023
Q2 | $237K | Buy |
2,882
+1,526
| +113% | +$223K | ﹤0.01% | 2030 |
|
|
2023
Q1 | $139K | Sell |
1,356
-4,052
| -75% | -$569K | ﹤0.01% | 2094 |
|
|
2022
Q4 | $792K | Buy |
5,408
+1,791
| +50% | +$303K | ﹤0.01% | 1635 |
|
|
2022
Q3 | $611K | Buy |
3,617
+2,681
| +286% | +$436K | ﹤0.01% | 1701 |
|
|
2022
Q2 | $108K | Buy |
936
+428
| +84% | +$40.3K | ﹤0.01% | 2081 |
|
|
2022
Q1 | $51K | Buy |
+508
| New | +$59.3K | ﹤0.01% | 2183 |
|
|
2021
Q4 | – | Sell |
-493
| Closed | -$116K | – | 2247 |
|
|
2021
Q3 | $116K | Hold |
493
| – | – | ﹤0.01% | 2194 |
|
|
2021
Q2 | $167K | Sell |
493
-1,364
| -73% | -$516K | ﹤0.01% | 2157 |
|
|
2021
Q1 | $751K | Buy |
1,857
+235
| +14% | +$114K | ﹤0.01% | 1678 |
|
|
2020
Q4 | $1.08M | Sell |
1,622
-244
| -13% | -$136K | ﹤0.01% | 1463 |
|
|
2020
Q3 | $869K | Sell |
1,866
-244
| -12% | -$123K | ﹤0.01% | 1486 |
|
|
2020
Q2 | $1.24M | Buy |
2,110
+1,302
| +161% | +$445K | ﹤0.01% | 1375 |
|
|
2020
Q1 | $118K | Buy |
+808
| New | +$141K | ﹤0.01% | 1948 |
|